Knowledge and Early Adoption of the HPV Vaccine Among Girls and Young Women: Results of a National Survey
Knowledge and Early Adoption of the HPV Vaccine Among Girls and Young Women: Results of a National Survey
复制标题
DOI：
10.1016/j.jadohealth.2009.04.021
复制
发表时间：
2009-11-01
影响因子：
7.6
通讯作者：
Alexander, G. Caleb
中科院分区：
文献类型：
--
作者：
Caskey, Rachel;Lindau, Stacy Tessler;Alexander, G. Caleb
目的：2006年，9-26岁女性普遍接种人乳头状瘤病毒(HPV)疫苗成为正式建议，但对这种疫苗的知识和使用情况知之甚少。方法：对13-26岁女性的横断面调查来自具有全国代表性的小组，由Knowledge Networks，Inc.(Menlo Park，CA)开发和维护。结果：(A)有关HPV和HPV疫苗的知识，(B)采用疫苗的障碍，以及(C)早期接种疫苗的患病率和相关性。结果：总体而言，2143名受试者中有1011人(47%)完成了调查。30%的13至17岁的青少年和9%的18至26岁的青少年报告至少接受过一次HPV注射。对HPV的了解各不相同；然而，5%或更少的受试者认为HPV疫苗排除了定期宫颈癌筛查或安全性行为的需要。对医疗保健利用和信息来源进行调整后，报告最近一次医疗保健就诊(调整后的优势比[AOR]7.31，可信区间[CI]2.00-26.8)并报告与医疗保健提供者讨论HPV疫苗(AOR 4.50，CI 1.02-19.90)的13至17岁青少年更有可能接受疫苗接种；在18-26岁的青少年中，更有可能与家人或医疗保健提供者讨论HPV疫苗(AOR 3.08，CI 1.21-7.80)(AOR 11.92，CI 2.62-54.27)。结论：很少有女孩和年轻妇女认为HPV疫苗具有超出疫苗真实影响的保护作用。尽管感染人数适中，但许多有感染HPV风险的女性尚未接种疫苗。这些发现表明，医疗保健提供者和父母在采用HPV疫苗方面都发挥了重要作用。(C)2009年青少年医学会。版权所有。
Purpose: In 2006, universal human papillomavirus (HPV) vaccination of females ages 9 to 26 years became a formal recommendation, yet little is known about knowledge and adoption of this vaccine.Methods: A cross-sectional survey of females aged 13 to 26 years was drawn from a nationally representative panel, and developed and maintained by Knowledge Networks, Inc. (Menlo Park, CA). Outcome measures included: (a) knowledge about HPV and the HPV vaccine, (b) barriers to vaccine adoption, and (c) prevalence and correlates of early vaccine receipt.Results: Overall, 1,011 of 2,143 subjects (47%) completed the survey. Thirty percent of 13- to 17-year-olds and 9% of 18- to 26-year-olds reported receipt of at least one HPV injection. Knowledge about HPV varied; however, 5% or fewer subjects believed that the HPV vaccine precluded the need for regular cervical cancer screening or safe-sex practices. Adjusting for healthcare utilization and sources of information, vaccine receipt was more likely among 13- to 17-year-olds who reported a recent healthcare visit (adjusted odds ratio [AOR] 7.31, confidence interval [CI] 2.00-26.8) and reported discussing the HPV vaccine (AOR 4.50, CI 1.02-19.90) with a healthcare provider; and more likely among 18- to 26-year-olds who reported discussing the HPV vaccine (AOR 3.08, CI 1.21-7.80) with family or a healthcare provider (AOR 11.92, CI 2.62-54.27).Conclusions: Few girls and young women believe that the HPV vaccine is protective beyond the true impact of the vaccine. Despite moderate uptake, many females at risk of acquiring HPV have not yet received the vaccine. These findings suggest the important role of both healthcare providers and parents in HPV vaccine adoption. (C) 2009 Society for Adolescent Medicine. All rights reserved.